This prospective, randomized, double-blind, placebo-controlled study evaluated the effectiveness of intravenous lidocaine to reduce post-operative pain in 64 inguinal herniorrhaphy patients. Intravenous bolus injection of 1.5 mg/kg lidocaine followed by a continuous lidocaine infusion of 2 mg/kg per h was randomly assigned to 32 patients (lidocaine group) and intravenous normal saline bolus injection followed by infusion of normal saline was assigned to 32 other patients (control group). Visual analogue scale pain scores, fentanyl consumption and the frequency at which analgesia was administered from a patient-controlled analgesia device (measured by number of button pushes) were significantly lower in the lidocaine group than in the control group until 12 h after surgery. Total fentanyl consumption (patient-controlled plus investigator-controlled rescue administration) and the total number of button pushes were significantly lower in the lidocaine group than in the control group. It is concluded that intravenous lidocaine injection reduced post-operative pain after inguinal herniorrhaphy, is easy to administer and may have potential to become routine practice for this type of surgery.
Introduction
Inguinal herniorrhaphy is one of the most commonly performed operations in Korea and is frequently performed on a fast-track basis for which early post-operative pain relief is imperative. 1 This procedure is frequently associated with persistent postoperative pain that leads to the increased consumption of analgesics, delayed bowel function and other complications. 2 Furthermore, the requirement for rescue analgesics raises the risk of adverse effects, especially respiratory depression, emesis and sedation, which can lead to increased duration of hospital stay and thereby reduce the advantages of fast-track surgery. 3 -5 Continuous research is being done to identify effective adjuvant therapies to reduce the use of opioids; currently available therapies include ilioinguinal nerve H Kang, B-G Kim Intravenous lidocaine and inguinal herniorrhaphy blockade, 6 ilioinguinal neurectomy, 7 caudal blockade, 8 or the depositing of local anaesthetics directly into the wound. 9 These procedures can, however, add to the workload of clinicians and surgeons, and cannot be performed in patients with local infection in the block region or bleeding diathesis, or in those who have taken aspirin within the previous week. An alternative approach to pain relief is the use of intravenous lidocaine. This method of analgesia has been associated with reductions in post-operative pain, analgesic consumption, nausea, vomiting and length of hospital stay. 10, 11 Furthermore, intravenous lidocaine is easy to administer and is applicable when regional blockade is contraindicated. Little or no work, however, seems to have been done on the efficacy of intravenous lidocaine for pain relief after inguinal herniorrhaphy. The current prospective, randomized, double-blind, placebo-controlled study was, therefore, set up to evaluate the effects of intravenous lidocaine on post-operative pain and requirements for analgesics after inguinal herniorrhaphy.
Patients and methods

PATIENTS
All patients aged 18 -65 years who were scheduled, between December 2009 and September 2010, to undergo elective unilateral inguinal hernia surgery at ChungAng University Hospital, Seoul, Republic of Korea, and were suitable for the Bassini repair technique 12 under general anaesthesia were assessed for study eligibility. Patients who weighed < 45 kg or > 100 kg, had severe underlying cardiovascular (especially atrioventricular block), renal or hepatic disease and were allergic to local anaesthetics were excluded. Patients were also excluded if they had received opioids or non-steroidal anti-inflammatory drugs within the previous 1 week or were taking these drugs chronically as pain treatment.
The study protocol was approved by the Institutional Review Board of the College of Medicine of Chung-Ang University, and the study was carried out according to the principles of the Declaration of Helsinki, 2000. Written informed consent was obtained from all participants before inclusion in the trial.
RANDOMIZATION PROTOCOL
Randomization was based on computerized random-number generation. The group assignments were kept in a set of sealed envelopes, each bearing only the case number on the outside. Several hours before surgery, the appropriate envelope was opened by the pharmacist and the card inside determined whether the patient would be in the control group or the intravenous lidocaine group. Patients in the control group received an intravenous normal saline bolus, then continuous infusion of normal saline, and those in the lidocaine group received an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous infusion of 2 mg/kg per h. Lidocaine or normal saline were prepared by the pharmacist in the form of two syringes for each patient, labelled with the case number and 'bolus' or 'infusion'. A specially trained investigator was responsible for data collection during the post-operative period. All patients, surgeons, anaesthesiologists and the investigator collecting data were unaware of patients' group assignments.
DRUG ADMINISTRATION AND ANAESTHESIA FOR SURGERY
The patients in the lidocaine group received the bolus injection of lidocaine 2 min before orotracheal intubation. Continuous H Kang, B-G Kim Intravenous lidocaine and inguinal herniorrhaphy intravenous infusion of lidocaine was started immediately and continued during the operation. The patients in the control group received the saline injections in the same manner.
General anaesthesia was induced with 5 mg/kg intravenous thiopental and 0.6 mg/kg intravenous rocuronium. The trachea was intubated and ventilation was controlled at a tidal volume of 10 ml/kg and at a respiratory rate of 10 breaths/min. Anaesthesia was maintained with 2 -3% sevoflurane and 50% nitrous oxide in oxygen. Non-invasive arterial blood pressure, electrocardiograms and pulse oximetry were continuously monitored. During surgery the patients received an intravenous infusion of lactated Ringer's solution at a rate of 3 -6 ml/kg per h. No additional intravenous opioids were injected.
SURGICAL TECHNIQUE
All the operations were carried out by the same team of surgeons. The Bassini repair technique was used. 12 Reconstruction of the inguinal floor was accomplished by suturing the transversus abdominis and internal oblique musculoaponeurotic arches or the conjoined tendon (if present) to the inguinal ligament. Six to eight interrupted sutures were inserted 2 -3 cm back from the cut edges. The repair began medially to the periosteum of the pubis and the inguinal ligament and extended 1 cm beyond the internal inguinal ring, which was tightened with interrupted sutures done with 1/0 black silk. The external oblique aponeurosis was closed with interrupted sutures done with 2/0 black silk.
POST-OPERATIVE PAIN CONTROL, MONITORING AND CARE
Post-operative pain intensity was measured by patients using a 100 mm visual analogue scale (VAS; 0 mm, no pain; 100 mm, worst possible pain) and patients in both groups were taught how to use a computerized, patient-controlled analgesia (PCA) system (Automed 3300 TM ; ACE Medical, Seoul, Republic of Korea) to control post-operative pain.
The mode of post-operative analgesia was continuous infusion of 0.1 µg/kg per h fentanyl plus, by pushing a button on the PCA system, on-demand release of a 0.1 µg/kg bolus (total regimen of 100 ml of fentanyl); the PCA had a lockout period of 15 min. In the case of a persistent VAS pain score > 30 mm, an additional rescue analgesia dose of 50 µg fentanyl was injected intravenously by an investigator to lower the VAS pain score to < 30 mm.
Post-operative nausea and vomiting were treated with 4 mg intravenous ondansetron (GlaxoSmithKline, Uxbridge, UK) as required.
Oral intake of solid food was started as soon as patients could tolerate it and bowel function became adequate. The patients were discharged as soon as they were able to eat an adequate oral diet and were mobile.
STUDIED VARIABLES
The age, sex, American Society of Anesthesiologists physical status, height, weight, duration of anaesthesia (from injection of thiopental to extubation) and duration of operation (from the patient's entry into until removal from the operating room) were recorded for each patient. Furthermore, the patients were instructed to record the exact time of passing their first flatus.
The VAS pain scores were recorded at 2, 4, 8, 12, 24 and 48 h after surgery. The frequency of bolus release from the PCA system and analgesia consumption (patientcontrolled fentanyl delivered by the PCA system plus rescue analgesia) were assessed for 0 -2, 2 -4, 4 -8, 8 -12, 12 -24 and 24
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-48 h post-surgery.
The frequencies of post-operative nausea and vomiting were noted. The time to ingesting a regular diet and the length of hospital stay were collected for each patient and taken as a reflection of the rate of recovery.
STATISTICAL ANALYSES
The primary outcome variable was the VAS pain score 2 h after surgery. A pilot study was conducted where VAS pain scores were recorded 2 h after surgery for 10 patients who had received intravenous normal saline. The SD of the score in this group was ± 28 mm. For power calculation, a similar SD was assumed for patients receiving intravenous lidocaine. To estimate the group size needed to show statistical significance, assuming a between-group difference in VAS pain score of 20 mm at 2 h after surgery, with a two-tailed α = 0.05 and power of 80%, it was calculated that a minimum of 32 patients/group was required.
For comparisons between groups, the distribution of the data was first evaluated for normality with the Shapiro-Wilk test. Normally distributed data were presented as mean ± SD and the groups were compared with the Student's t-test. Non-normally distributed data were expressed as median (interquartile range) and were analysed with the Mann-Whitney U-test.
Descriptive variables were subjected to χ 2 analysis or Fisher's exact test, as appropriate, and P < 0.05 was deemed a showing statistical significance. Pearson's correlation coefficient was used to measure correlations between the VAS pain score and the frequency of PCA-delivered bolus, and between the VAS pain score and the total fentanyl consumption, and data were reported as mean ± SE. Statistical analysis was performed with SPSS ® statistical package version 18.0 (SPSS Inc., Chicago, IL, USA).
Results
From a total of 87 patients scheduled to undergo elective unilateral inguinal hernia surgery and assessed for study eligibility, 64 patients were consecutively selected and randomly assigned to each of the two groups. The groups did not differ with respect to age, gender, American Society of Anesthesiologists physical status grade, height, weight, duration of anaesthesia, or duration of operation (Table 1) .
One patient in the control group was Lidocaine group: patients given an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous intravenous infusion of 2 mg/kg per h. Control group: patients given a placebo intravenous normal saline bolus injection followed by infusion of normal saline.
No statistically significant between-group differences (P > 0.05). IQR, interquartile range; ASA, American Society of Anesthesiologists.
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excluded from the study at the conclusion of the operation as meperidine was required to treat post-operative shivering. Another patient who fit the inclusion criteria replaced this patient.
The results for VAS pain scores are shown in Fig. 1 . In both groups, the highest VAS pain levels were experienced 2 h after surgery and the pain gradually diminished in all patients over time. The VAS pain scores in the lidocaine group were significantly lower than in the control group until 12 h after surgery (P < 0.05). Despite PCA-administered and rescue analgesia, some patients reported VAS pain scores > 30 mm after surgery and were given additional injections of fentanyl. The numbers of patients who required additional injection of fentanyl at 2, 4, 8 and 12 h after surgery were 5, 2, 3, 1 in the control group and 3, 2, 1, 0 in the lidocaine group, respectively. No patient in either group required additional injection of fentanyl at 24 and 48 h.
Fentanyl consumption and the frequency of PCA button pushes were significantly lower in the lidocaine group than in the control group until up to 12 h after surgery (P < 0.05; Figs 2 and 3) . The values for these two variables gradually decreased in both groups over time. Total fentanyl consumption (patient-controlled plus rescue administration) was significantly lower in the lidocaine group than in the control group (P < 0.05; Fig. 4) , and total number of PCA button pushes was 44% lower in the lidocaine group than in the control group (P < 0.05; Fig. 5 ).
Increased VAS pain scores correlated significantly with increased PCA button push frequency (r = 0.404, P = 0.000) and with increased fentanyl consumption (r = 0.394, P = 0.000).
The frequency of nausea was significantly lower in the lidocaine group than in the control group (P = 0.021), but vomiting rates did not differ significantly between the FIGURE 1: Comparison of visual analogue scale (VAS) pain scores for 32 inguinal herniorrhaphy patients given an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous intravenous infusion of 2 mg/kg per h (lidocaine group) and 32 patients given a placebo intravenous normal saline bolus injection followed by infusion of normal saline (control group) (mean ± SE; *P < 0.05 versus control group) 
FIGURE 2:
Comparison of fentanyl consumption for 32 inguinal herniorrhaphy patients given an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous intravenous infusion of 2 mg/kg per h (lidocaine group) and 32 patients given a placebo intravenous normal saline bolus injection followed by infusion of normal saline (control group) (mean ± SE; *P < 0.05 versus control group) 
FIGURE 3:
Comparison of the frequency of button pushes (FBP) on the patientcontrolled intravenous analgesia device to release a 0.1 µg/kg lidocaine bolus for 32 inguinal herniorrhaphy patients given an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous intravenous infusion of 2 mg/kg per h (lidocaine group) and 32 patients given a placebo intravenous normal saline bolus injection followed by infusion of normal saline (control group) (mean ± SE; *P < 0.05 versus control group) Table 2) .
The time to first flatus was significantly shorter in the lidocaine group than in the control group (P = 0.003). The number of days in hospital and the time to starting a regular oral diet were also shorter in the lidocaine group, but these differences failed to reach statistical significance ( Table 2 ).
Discussion
The results of this study indicate that perioperative use of intravenous lidocaine significantly reduces pain and opioid consumption after surgery compared with placebo in inguinal herniorrhaphy patients. The lower total frequency of PCA button pushes in patients given lidocaine reflected better subjective patient satisfaction in terms of pain.
Inguinal hernia repair is frequently associated with persistent post-operative discomfort and distress for patients and, consequently, late discharge from hospital. 2 In the present study, despite the use of postoperative PCA and rescue analgesia, mean VAS pain scores in the control group were > 30 mm at 4 h after surgery, which reflects notable post-operative pain. Acute post- 
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operative pain has been reported to lead to chronic pain in 12 -47% of hernia patients. 13 The Bassini technique was selected as the inguinal repair method for the present study because of its low cost and, since it does not use synthetic mesh, the absence of risk of foreign-body reaction. This technique, however, results in more intense postoperative pain than tension-free repair, which makes aggressive post-operative analgesia imperative. 12 Perioperative analgesia has traditionally been achieved with opioid analgesics, but these drugs carry risks of side-effects, especially respiratory depression, emesis and sedation. 3 -5 Moreover, excessive use of potent opioids can increase post-operative pain as a result of their rapid elimination from the body and the development of acute tolerance. 14 Although various methods have been investigated to reduce post-operative pain and, therefore, to decrease opioid use after inguinal herniorrhaphy, such as ilioinguinal nerve blockade, 6 ilioinguinal neurectomy, 7 caudal blockade, 8 or the depositing of local anaesthetics directly into the wound, 9 these extra procedures place an increased burden on surgeons and clinicians, and they are unsuitable for some patients, such as those with local infection in the block region, bleeding diathesis, or those who have taken aspirin within the previous week. An alternative approach to reduce pain after inguinal herniorrhaphy is perioperative intravenous administration of lidocaine. This drug is an amide local anaesthetic that has many pharmacological features, such as antiarrhythmic, 15 analgesic   16   and anti-inflammatory properties. 17 Intravenous lidocaine infusion has been used to relieve cancer pain, 18 chronic pain 19 and diabetic neuropathies, 20 and has been shown to reduce VAS pain scores, analgesic requirements and the time to first use of analgesia after surgery. 21, 22 The mechanism of action is believed to be blockade of the nociceptive impulses, both peripherally 16, 23 and centrally, 24, 25 and it is assumed that sodium channel blockade, 17 muscarinic receptor blockade, 26 N-methyl-Daspartate receptor blockade, 27 and inhibition of polymorphonuclear leucocyte priming and activation 28 are involved.
The results of the present study are consistent with those from previous studies in which perioperative use of intravenous 7.00 (5.00 -9.00) 9.00 (8.00 -12.00) P = 0.003 Time in hospital, days, median (IQR) 2.00 (2.00 -3.00) 3.00 (2.00 -3.00) NS Time to start a regular diet, days, 1.00 (1.00 -2.00) 2.00 (1.00 -2.00) NS median (IQR) Lidocaine group: patients given an intravenous bolus of 1.5 mg/kg lidocaine followed by a continuous intravenous infusion of 2 mg/kg per h. Control group: patients given a placebo intravenous normal saline bolus injection followed by infusion of normal saline. NS, no statistically significant between-group difference (P > 0.05); IQR, interquartile range.
lidocaine has been shown to improve postoperative analgesia.
10,11 Groudine et al. 11 reported that a 1.5 mg/kg bolus of lidocaine followed by continuous infusion of 3 mg/min during radical prostate surgery and in the post-analgesia care unit significantly reduced post-operative pain, the demand for morphine in the post-analgesia care unit and the demand for ketorolac in the ward. Kaba et al. 10 showed that, in patients undergoing laparoscopic colectomy, a bolus of 1.5 mg/kg lidocaine followed by continuous infusion of 2 mg/kg per h intraoperatively and 1.33 mg/kg per h for 24 h post-operatively reduced opioid consumption during and within the first 24 h after surgery, and reduced post-operative pain during mobilization and coughing.
Some studies, however, have shown no notable analgesic effect with intravenous lidocaine in the post-operative period. 29, 30 Martin et al. 29 demonstrated that an intravenous bolus of 1.5 mg/kg lidocaine 30 min before surgical incision for total hip arthroplasty followed by continuous infusion of 1.5 mg/kg per h until 1 h after skin closure offered no beneficial effect on post-operative analgesia and morphine consumption, compared with placebo. Insler et al. 30 reported that, in patients who underwent coronary artery bypass grafting, an intravenous bolus of 1.5 mg/kg lidocaine followed by continuous infusion of 30 µg/kg per min during and until 48 h after surgery had no effect on post-operative pain and fentanyl use compared with placebo. We assume that discrepancies between studies are related to the different types of surgery and the different doses of infused lidocaine.
In the present study, significant differences between patients given lidocaine and those given placebo in VAS pain scores, frequency of PCA button pushes and fentanyl consumption persisted until 12 h after surgery. This noticeable prolongation of the analgesic effect of lidocaine beyond the expected duration based on its pharmacokinetics 31 might be related to the prevention of central or peripheral hypersensitivity or the inhibition of Nmethyl-D-aspartate receptors. 32 Surgically induced abdominal pain causes sympathetic hyperactivity that inhibits intestinal motility and propulsive activity. 33 Moreover, excessive use of opioids may delay recovery of intestinal motility, whereas lidocaine has a direct excitatory effect on intestinal smooth muscle by blocking the inhibitory reflexes. 34 In addition, lidocaine reduces the inflammatory process by inhibiting cytokine secretion and triggering the secretion of anti-inflammatory mediators. 35 The time to first flatus in the present study was significantly shorter in the lidocaine group than in the control group. However, the number of days in hospital and the time to resume a regular oral diet for patients given lidocaine, although lower than the control patients, did not reach significance. One reason for the lack of significant differences between groups for the latter two features could be that these were not primary criteria. The optimum group size was determined by power calculation on the basis of VAS pain scores and, therefore, the number of patients included might have been too small to reach statistical significance for recovery rate endpoints. The use of different units to measure recovery rate variables (i.e. hours for the time to first flatus and days for the time spent in hospital and to resume a regular oral diet) might also have contributed to the non-significant results.
Post-operative nausea and vomiting are substantial problems, since even mild nausea and vomiting can delay discharge from hospital, leading to increased costs and 5 The present study showed a benefit of intravenous lidocaine infusion in terms of nausea, which might have been derived from a decrease in the post-operative use of opioids and the anti-inflammatory and propulsive effects of lidocaine. There was, however, no statistically significant effect on vomiting.
The present study has some limitations. First, the concentration of lidocaine in blood was not measured. Its measurement would have contributed to an improved understanding of the relationship between the pharmacokinetics of this drug and its systemic effects. Nevertheless, the present study used even smaller doses and a shorter duration of administration than were used in a previous study in which lidocaine was shown not to reach toxic concentrations and to have no side-effects. 10 Secondly, the exclusion criteria excluded some patients from the present study, so the results cannot be extrapolated to all patients, nor can the possibility of rare complications be completely ruled out.
On the other hand, some advantages of the current study are worth highlighting. Only patients suitable for elective unilateral inguinal herniorrhaphy achievable with the Bassini technique 12 to avoid variation due to the type, nature and duration of pain associated with different types of surgery were included. All the surgeries were performed by the same surgical team to minimize differences in tissue handling. Furthermore, all the observations were performed by one observer to eliminate any inter-observer variability. Thus, differences in pain relief can be assumed to reflect only variation in antinociceptive effectiveness.
In conclusion, perioperative intravenous lidocaine might be effective for improving pain control, reducing the need for opioid analgesics and for accelerating the return of bowel function in patients who undergo inguinal herniorrhaphy. The use of perioperative administration of intravenous lidocaine in inguinal herniorrhaphy may have potential to become a routine practice for this type of surgery.
